Your browser doesn't support javascript.
loading
RB1 loss induced small cell lung cancer transformation as acquired resistance to pembrolizumab in an advanced NSCLC patient.
Arakawa, Sayaka; Yoshida, Tatsuya; Shirasawa, Masayuki; Takayanagi, Daisuke; Yagishita, Shigehiro; Motoi, Noriko; Ohe, Yuichiro.
Affiliation
  • Arakawa S; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: tatyoshi@ncc.go.jp.
  • Shirasawa M; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Takayanagi D; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Yagishita S; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan.
  • Motoi N; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Lung Cancer ; 151: 101-103, 2021 01.
Article in En | MEDLINE | ID: mdl-33279272

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Ubiquitin-Protein Ligases / Small Cell Lung Carcinoma / Retinoblastoma Binding Proteins / Antibodies, Monoclonal, Humanized / Lung Neoplasms Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Japan Country of publication: Ireland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Ubiquitin-Protein Ligases / Small Cell Lung Carcinoma / Retinoblastoma Binding Proteins / Antibodies, Monoclonal, Humanized / Lung Neoplasms Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Japan Country of publication: Ireland